We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GSK, Genmab’s Arzerra Wins FDA Panel Recommendation
GSK, Genmab’s Arzerra Wins FDA Panel Recommendation
May 29, 2009
The FDA’s Oncologic Drugs Advisory Committee has recommended that the agency approve GlaxoSmithKline (GSK) and Genmab’s Arzerra to treat chronic lymphocytic leukemia (CLL).